EpiBiologics develops first-in-class antibody based targeted therapies against membrane and extracellular proteins that drive underlying disease biology.
Specifica, an IQVIA business
3 followers
Milestone Pharmaceuticals
1 follower
Normunity
1 follower
Johnson & Johnson
678 followers
ADARx Pharmaceuticals
4 followers
Philips
317 followers
Vertex Pharmaceuticals
114 followers
Natera
34 followers
Exelixis
17 followers
BioXcellerator
1 follower
Need
2 followers
MRIguidance
1 follower